Ahmed El-Sayed Hassan

Dr. Ahmed El-Sayed Hassan

Zagazig University, Zagazig, Egypt
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
HEHany Ahmed Elkattawy
Hany Ahmed Elkattawy
SMSamar Mortada
Samar Mortada
AHAhmed El-Sayed Hassan
Ahmed El-Sayed Hassan
ABAhmed Behiry
Ahmed Behiry
HEHasnaa Ali Ebrahim
Hasnaa Ali Ebrahim
SESherein F. El-Sayed
Sherein F. El-Sayed
Background: The harmful consequences of non-alcoholic fatty liver disease (NAFLD) are posing an increasing threat to public health as the incidence of diabetes and obesity increases globally. A non-invasive treatment with a range of autonomic and metabolic benefits is transcutaneous vagus nerve stimulation (tVNS). Aim of the study: To investigate the possible preventive impacts of VNS against adult rats’ NAFLD caused by a high-fat diet (HFD) and to clarify the underlying mechanisms. Methods: A total of thirty-two adult male rats were split into two groups: the HFD-induced NAFLD group (n = 24) and the control normal group (n = 8). The obesogenic diet was maintained for 12 weeks to induce hepatic steatosis. The HFD-induced NAFLD group (n = 24) was separated into three groups: the group without treatment (n = 8), the group with sham stimulation (n = 8), and the group with VNS treatment (n = 8). VNS was delivered for 30 min per day for 6 weeks after the establishment of NAFLD using a digital TENS device. The subsequent assessments included hepatic triglyceride, cholesterol content, serum lipid profile, and liver function testing. In this context, inflammatory biomarkers (TNF-α, IL-6) and hepatic oxidative stress (MDA, SOD, and GPx) were also assessed. To clarify the possible mechanisms behind the protective benefits of VNS, additional histological inspection and immunohistochemistry analysis of TNF-α and Caspase-3 were performed. Results: In the NAFLD-affected obese rats, VNS markedly decreased the rats’ body mass index (BMI) and abdominal circumference (AC). Liver function markers (albumin, ALT, and AST) and the serum lipid profile—which included a notable decrease in the amounts of hepatic triglycerides and cholesterol—were both markedly improved. Additionally, oxidative stress and inflammatory indicators showed a considerable decline with VNS. Notably, the liver tissues examined by histopathologists revealed that there is evidence of the protective impact of VNS on the oxidative and inflammatory states linked to HFD-induced NAFLD while maintaining the architectural and functional condition of the liver. Conclusions: Our findings suggest that VNS may represent a promising therapeutic candidate for managing NAFLD induced by obesity. It can be considered to be an effective adjuvant physiological intervention for the obese population with NAFLD to spare the liver against obesity-induced deleterious injury.

1 May 2023 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
AHAhmed El-Sayed Hassan
Ahmed El-Sayed Hassan
SHShimaa Hadhoud
Shimaa Hadhoud
EEEssam Elmahdi
Essam Elmahdi
HEhany elkattawy
hany elkattawy
Myocardial infarction is among the leading causes of mortality. Menaquinone-4 (MK-4), a vitamin K2 analog, might play a role in rescuing cardiac ischemia/reperfusion (I/R) injury. This work aimed to discover the potential cardioprotective role of MK-4 against myocardial I/R injury in rats. Thirty-two rats were categorized into three groups: (I/R) control Group: subjected to I/R protocol (received vehicle); MK-4 preconditioning group: MK-4 infusion for 20 minutes before the I/R protocol; MK-4 postconditioning group: MK-4 infusion for 20 minutes at the start of the reperfusion phase. The hearts were placed in the Langendorff apparatus, and the left ventricular developed pressure (LVDP), heart rate (HR), + (LV dP/dt) max, - (LV dP/dt) max, and Tau were calculated. The necrotic mass was determined by staining it with nitro blue tetrazolium. Creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and C- reactive protein (CRP), as well as cardiac superoxide dismutase (SOD), nitric oxide (NOx), malondialdehyde (MDA), and glutathione (GSH) levels, were all evaluated. MK-4 postconditioning significantly reduced myocardial infarct size, increased LVDP, + (LV dp/dt) max, - (LV dp/dt) max, and HR, reduced Tau, CK-MB, LDH, CRP, IL-6, TNF-α, MDA and NOx levels, and increased SOD activity whereas no significant difference in the GSH level was detected. In conclusion, these data imply that MK-4 may protect the heart from the consequences of I/R.

Verified
Journal Article
Closed access
AEAhmed Ibrahim Abd Elneam
Ahmed Ibrahim Abd Elneam
GAGhadah Alhetheli
Ghadah Alhetheli
MAMohammed Saleh Al-Dhubaibi
Mohammed Saleh Al-Dhubaibi
AAAli Ismaeil Ali Abd Alrheam
Ali Ismaeil Ali Abd Alrheam
AHAhmed El-Sayed Hassan
Ahmed El-Sayed Hassan

1 October 2023 in International Journal of Morphology
Verified
Journal Article
Open access
PDF file
HEHany A Elkattawy
Hany A Elkattawy
AHAhmed El-Sayed Hassan
Ahmed El-Sayed Hassan
AEAmira Ebrahim-Alsemeh
Amira Ebrahim-Alsemeh
OAOla A Abdelwahab
Ola A Abdelwahab
MEMamdouh Eldesoqui
Mamdouh Eldesoqui
SHShimaa Hadhoud
Shimaa Hadhoud
The main cause of mortality and disability globally is myocardial infarction (MI). Isoproterenol (ISO), a β-adrenoceptor agonist, has been used to induce rat myocardial necrosis. Whereas interleukin-37 (IL-37) has anti-inflammatory and cytoprotective properties. The study aimed to investigate the potential protective effects of IL-37 administration on cardiac architecture, oxidative stress, and inflammatory markers during ISO-induced MI in rats. Three groups of adult male rats were used in this study, the normal control group (n=8), ISO-induced MI group (n=8) that received isoproterenol hydrochloride (ISO) (100 mg/kg/day, SC, for the first 2 consecutive days), and IL-37-treated group (ISO+IL-37) (n=8) that received recombinant human IL-37 (40 µg/kg /day, intraperitoneally, for 2 weeks during and after ISO injections. Heart rate (HR.) and ECG changes were monitored. Some oxidative stress markers such as superoxide dismutase (SOD), nitric oxide (NOx), malondialdehyde (MDA), and glutathione (GSH) tissue levels in the tissue homogenate were assayed. Interleukin- 6 (IL-6), tumor necrosis factor- α (TNF-α), caspase-8, P53, and C- reactive protein (CRP) were among the inflammatory markers examined. In addition, serum levels of creatinine kinase (CK-MB) and lactate dehydrogenase (LDH) were analyzed to evaluate the myocardial injury. For histological analysis, tissues were sectioned, fixed in paraffin, and stained with hematoxylin and eosin (H&E), Masson Trichrome and, immunohistochemical against NF-kB, TNF-α, and Caspase-9. IL-37 improved ECG changes, cardiac enzyme markers, and some inflammatory markers of oxidative stress in ISO-induced MI. It also improved the histopathological and immunohistochemical changes in MI. In conclusion: IL-37 might be a promising therapeutic modality in myocardial infarction.

1 December 2017 in The Egyptian Journal of Forensic Sciences and Applied Toxicology
Verified
Journal Article
Open access
PDF file
EKEman El-Sayed Hassan Khayal
Eman El-Sayed Hassan Khayal
AEArwa A. El-Sheikh
Arwa A. El-Sheikh
AHAhmed El-Sayed Hassan
Ahmed El-Sayed Hassan
Toxicity from antidepressant agents is considered a common phenomenon. The aim of this study was to estimate the role of intravenous lipid emulsion (ILE) as compared to sodium bicarbonate (Na bicarbonate) as a main line or as an adjunctive therapy for treatment of cardiovascular toxicity induced by concurrent single oral administration of amitriptyline and citalopram in rats. The intoxicated rats were equally divided into three groups. Group1 received a bolus dose of 2mEq/kg Na bicarbonate then by infusion of 0.25ml/kg/min. Group 2 received a bolus dose of 1.5ml /kg of 20% ILE followed by infusion of 0.25 ml/kg/min and increased stepwise to 12.4 ml/kg. Group 3 received Na bicarbonate + ILE by the same pattern and doses. All therapies were injected for 60 min. Mean arterial blood pressure (MAP), heart rate (HR) and electrocardiogram for QRS duration were assessed across all intervals with comparison of pH recordings before and after therapies. The results showed significant improvement of MAP and QRS prolongation after the iv bolus dose, along infusion period and even after 10 min of the follow up. HR was not changed in all groups while pH showed significant improvement after the end of therapies administration in all groups. No significant differences were found between Na bicarbonate and ILE groups while there was a highly significant improvement in Na bicarbonate + ILE group as compared to the other groups. In conclusion, ILE can be used alone or as an adjunctive therapy with Na bicarbonate which is preferred to reverse the cardiovascular toxicity induced by combined antidepressant agents in adult rats

25 March 2024 in International Clinical Psychopharmacology
Verified
Journal Article
Closed access
EAEman Ali
Eman Ali
MMMona Ahmed Abdel Maksoud
Mona Ahmed Abdel Maksoud
SAShaymaa M Arafa
Shaymaa M Arafa
DIDoaa Ibrahim
Doaa Ibrahim
AHAhmed El-Sayed Hassan
Ahmed El-Sayed Hassan
AEAhmed Embaby
Ahmed Embaby
Hepatocyte injury is assessed by serum aspartate transaminase and alanine transaminase estimation. In psychiatric populations, antipsychotic drugs (AD) are culprit in hepatic dysfunction. To assess transaminitis among psychiatric patients treated by AD. This cross-sectional study was conducted in Zagazig University Hospitals in Egypt, from December 2022 to February 2023. A total of 135 adult patients aged ≥ 18 years, were diagnosed with psychiatric disorders after exclusion of patients receiving any hepatotoxic drugs, viral hepatitis, having chronic liver or kidney diseases, diabetes mellitus, mental retardation, and pregnant females. Among the 135 patients, 104 (77.0%) were males. Their age was 32 ± 9, The most popular used class of AD was atypical AD 84 (62.2%). The overall incidence of transaminitis among patients receiving AD was 23/135 (17.04%) of patients; 13 (56.5%) were on atypical AD compared to 10 (43.5%) patients receiving combined AD, without any statistically significant difference. The use of AD in patients with psychiatric disorders is potentially safe with minimal transaminitis (<one-fold elevation). However, baseline and regular monitoring of serum aminotransferase is recommended during treatment.